MRI and characterization of atherosclerotic plaque: Emerging applications and molecular imaging

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 7, 2002, Pages 1065-1074

  Choudhury, Robin P ^a   Fuster, Valentin ^b   Badimon, Juan J ^b   Fisher, Edward A ^b   Fayad, Zahi A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Mice; Molecular imaging; MRI; Plaque

Indexed keywords

COLESTIPOL; CONTRAST MEDIUM; GADODIAMIDE; GADOFOSVESET; GADOLINIUM; MEVINOLIN; NICOTINIC ACID;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RABBIT; REVIEW; THROMBOGENESIS; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; THROMBOSIS;

EID: 0036067779     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000019735.54479.2F     Document Type: Review

References (140)

1. A new technique for the arteriographic examination of the abdominal aorta and its branches
2. The history of interventional cardiology: Cardiac catheterization, angioplasty, and related interventions
3. Follow-up of patients from the coronary artery surgery study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty
4. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979: The Coronary Artery Surgery study
5. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
6. Compensatory enlargement of human atherosclerotic coronary arteries
7. Arterial remodeling: Mechanisms and clinical implications
8. Angiographic progression of coronary artery disease and the development of myocardial infarction
9. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
10. Coronary plaque disruption
11. Acute coronary syndromes: Biology
12. The stabilized plaque: Will the dream come true?
13. Tomographic (plaque) imaging: State of the art
14. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque
15. Imaging arterial wall disease
16. Natural history of aortic and coronary atherosclerotic lesions in youth: Findings from the PDAY Study
17. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
18. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study
19. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
20. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
21. Coronary plaque erosion without rupture into a lipid core: A frequent cause of coronary thrombosis in sudden coronary death
22. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
23. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
24. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo
25. Serial magnetic resonance imaging of experimental atherosclerosis allows visualization of lesion characteristics and lesion progression in vivo
26. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging
27. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice
28. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model
29. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis
30. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: An in vivo study in rabbits
31. Nuclear magnetic resonance imaging of atherosclerotic disease
32. Noninvasive quantitative evaluation of atherosclerosis using MRI and image analysis
33. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo
34. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging
35. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging
36. Principles of magnetic resonance imaging
37. Magnetic resonance imaging of the heart
38. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: An intravascular ultrasound study in vivo
39. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
40. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content
41. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
42. Macrophages and atherosclerotic plaque stability
43. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
44. Chemical shift magnetic resonance imaging of human atheroma
45. Magnetic resonance chemical shift imaging and spectroscopy of atherosclerotic plaque
46. George Lyman Duff memorial lecture: Progression and regression of atherosclerotic lesions: Insights from lipid physical biochemistry
47. 13C-NMR spectroscopy of human atherosclerotic lesions: Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction
48. MRI NMR spectroscopy of the lipids of atherosclerotic plaque in rabbits and humans
49. T2-weighted contrast for NMR characterization of human atherosclerosis
50. High-resolution 1H NMR spectral signature from human atheroma
51. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization
52. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging
53. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: A comparison with transesophageal echocardiography
54. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA
55. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging
56. Carotid atherosclerotic plaque: Noninvasive MR characterization and identification of vulnerable lesions
57. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques
58. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke
59. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition
60. Coronary magnetic resonance angiography for the detection of coronary stenoses
61. Improved high resolution MRI of human coronary lumen and plaque with a new cardiac coil
62. The impact of spatial resolution and respiratory motion on magnetic resonance plaque characterization
63. Free-breathing 3D coronary MRA. The impact of isotropic image resolution
64. High-resolution magnetic resonance imaging of normal and atherosclerotic human coronary arteries ex vivo: Discrimination of plaque tissue components
65. Structure of plaque at carotid bifurcation: High-resolution MRI with histological correlation
66. Contrast agents
67. Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography
68. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization?
69. Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology
70. Immunohistochemical study of intimal microvessels in coronary atherosclerosis
71. Too many vessels? Not enough? The wrong kind?: The VEGF debate continues
72. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization
73. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs
74. Apparent vessel wall inflammation detected using MS-325, a blood pool contrast agent
75. Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans
76. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits
77. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits
78. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles
79. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model
80. Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance
81. MR appearance of hemorrhage in the brain
82. Direct imaging of deep-vein thrombosis with magnetic resonance imaging
83. Diagnosis of lower-limb deep venous thrombosis: A prospective blinded study of magnetic resonance direct thrombus imaging
84. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli
85. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE)
86. In vivo non-invasive detection and age definition of arterial thrombus by MRI
87. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent
88. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques
89. Direct clot detection with MRI using a novel fibrin-targeted gadolinium agent
90. A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution
91. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events
92. Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease: Observations from the FATS Trial: Familial Atherosclerosis Treatment Study
93. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering
94. Progression and regression of atherosclerotic lesions: Monitoring with serial noninvasive magnetic resonance imaging
95. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study
96. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI
97. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden
98. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images
99. A semiautomatic technique for measurement of arterial wall from black blood MRI
100. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI
101. Interventional MRA and intravascular imaging
102. Intravascular MR imaging-guided balloon angioplasty with an MR imaging guide wire: Feasibility study in rabbits
103. Endovascular procedures under near-real-time magnetic resonance imaging guidance: An experimental feasibility study
104. High resolution intravascular imaging following magnetic resonance guided aortic stent placement
105. Magnetic resonance-guided coronary artery stent placement in a swine model
106. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene therapy
107. Intraoperative MR imaging guidance for intracranial neurosurgery: Experience with the first 200 cases
108. Endovascular interventional MR: Balloon angioplasty in a hemodialysis access flow phantom
109. Mouse models of atherosclerosis
110. Atherosclerosis and the mouse: A decade of experience
111. The emergence of mouse models of atherosclerosis and their relevance to clinical research
112. Learning from the transgenic mouse: Endothelium, adhesive molecules, and neointimal formation
113. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
114. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
115. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
116. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
117. Apo A-I inhibits foam cell formation in apo E-deficient mice after monocyte adherence to endothelium
118. Interleukin-6 exacerbates early atherosclerosis in mice
119. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
120. Rapid regression of atherosclerosis induced by liver-directed gene transfer of apoE in apoE-deficient mice
121. Complete atherosclerosis regression after human apoE gene transfer in apoE-deficient/nude mice
122. High-dose recombinant apolipoprotein a-i(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice: Potential implications for acute plaque stabilization
123. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?
124. Serial non-invasive high-resolution magnetic resonance imaging measures the progression of atherosclerosis in apolipoprotein E-deficient mice
125. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy
126. Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the carotid artery of the apolipoprotein-E null mouse
127. In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma
128. Dobutamine-stress magnetic resonance microimaging in mice: Acute changes of cardiac geometry and function in normal and failing murine hearts
129. Quantitative assessment of atherosclerotic lesions in mice
130. Molecular imaging
131. In vivo magnetic resonance imaging of transgene expression
132. In vivo visualization of gene expression using magnetic resonance imaging
133. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
134. The distribution of adhesion molecules in human atherosclerosis
135. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse
136. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging
137. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging
138. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles
139. Can receptors be imaged with MRI agents?